Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-034675

CEO and CFO bought 3,600 shares at an average $13.06 ($47,018)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2026-07-23 Purchase +2,500 $13.14 $32,850 5,606,602 D
Patel Snehal CEO and CFO 2026-07-24 Purchase +1,100 $12.88 $14,168 5,607,702 D
Open-market purchases · 3,600 sh · avg $13.06 · $47,018
Loading xslF345X06/ownership.xml…